Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Researchers have created a genetic map of prostate cancer by analyzing nearly 1,000 tumors, identifying eight mutational "fingerprints" that account for 85% of cases. Four of these patterns are linked to a higher risk of the cancer spreading. The findings could eventually help doctors personalize treatment and flag high-risk patients earlier.
Scientists from the University of Copenhagen, Rigshospitalet, and international partners have published a landmark study in Nature that maps the genetic processes driving prostate cancer. By analyzing nearly 1,000 prostate tumors, the team identified eight distinct mutational "fingerprints" — patterns left behind in the genome that reveal how and why cancer cells develop. Think of it like forensic science: the cancer gene is the culprit, and the genetic signatures are the fingerprints at the crime scene.
One of the study's biggest surprises is the role of DNA replication errors, which appear to drive roughly one-third of prostate cancer cases — far more than previously thought. Four of the eight fingerprint patterns were specifically linked to a higher risk of cancer spreading, particularly in testosterone-driven tumors.
By the Numbers:
Why it matters: Prostate cancer's biggest clinical challenge isn't detection — it's knowing which cases will stay harmless and which will turn aggressive. This genetic map brings doctors closer to answering that question, potentially guiding choices between chemotherapy and hormone therapy. While clinical validation is still needed, the method relies on sequencing technologies already in use, making real-world adoption feasible within a few years.
